期刊文献+

2型糖尿病肾病患者检测血清基质金属蛋白酶-10的意义 被引量:4

Study on the Significance of Detecting MMP-10 Level in Patients with Type 2 Diabetic Nephropathy
下载PDF
导出
摘要 目的探讨血清基质金属蛋白酶-10(MMP-10)水平与2型糖尿病肾病发病的关系。方法将100例2型糖尿病肾病患者按糖尿病肾病(DN)诊断标准分为糖尿病无肾病(DM)组(42例)与DN组(58例)。按照 Mogenson分期将DN组分为DN早期(DN1)30例,DN晚期(DN2)28例。另择60例健康体检者作为正常对照(NC)组。同时检测糖化血红蛋白(HbA1c)、肌酐(Scr)、尿素氮(BUN)、24 h尿微量清蛋白排泄率(UAER)、β2微球蛋白(β2-MG)和 MMP-10,进行相关的统计学分析。结果 DM,DN和 NC组 HbA1c,Scr,UAER,BUN,β2-MG和 MMP-10指标差异有统计学意义(F=6.478~10.892,均P<0.05)。DM组和 NC 组间除 HbA1c 外其它检测指标差异均无统计学意义(t=1.421~2.637,均 P>0.05),而DN组与NC组比较差异均有统计学意义(t=8.451~26.678,均P<0.05)。DN组和DM组间除 HbA1c外其它检测指标差异均有统计学意义(t=6.371~21.673,均P<0.05)。DN1组和DN2组间 HbA1c,Scr,UAER,BUN和β2-MG差异无统计学意义(t=0.891~1.385,均P>0.05)。而DN2组MMP-10水平明显比DN1组高,两组差异有统计学意义(t=86.371,P<0.01)。结论血清 MMP-10水平可能是2型糖尿病肾病患者肾脏损伤程度的靶标。 Objective To explore the significance of detecting serum MMP-10 in type 2 diabetic nephropathy.Methods 100 diabetic patients with suspected DN were devided into two groups,that was DM(42 cases)and DN(58 cases)group,and 60 casescontrolgroup(NC).By Mogenson,DN1(30 cases)and DN2(28 cases),HbA1c,BUN,Scr,UAER,β2-MG and MMP-10 leves were detected by the standard method.Results There were obvious differences of HbA1c,BUN,Scr,UAER,β2-MG and MMP-10 levels among DN,DM and NC(P〈0.05).Apart of HbA1c,others were no differences between DM group and NC group(P〉0.05).DN group was higher significantly than these in DM group(P〈0.05),and HbA1c,BUN,Scr,UAER, andβ2-MG levels had no statistical difference between DN1 and DN2 group.MMP-10 level in DN2 was higher than that in DN1 group(P〈0.05).Conclusion MMP-10 in serum may be a role indicator for impairment of renal function for diagnosis of type 2 diabetic nephropathy.
出处 《现代检验医学杂志》 CAS 2016年第3期111-113,共3页 Journal of Modern Laboratory Medicine
关键词 基质金属蛋白酶 10(MMP-10) 糖尿病肾病 肾功能 metalloproteinase-10 ( MMP-10) diabetic nephropathy(DN) renal function
  • 相关文献

参考文献2

二级参考文献32

  • 1Lelongt B,Legallicier B,Piedagnel R, et al. Matrix melalloproteinases MMP-2 and MMP-9(gelatinases) play a role in renal development, physiology and glomerular diseases?[J].Curr Nephrol Hypertens,2001,10(1):76.
  • 2Tanney DC,Feng L,Pollock AS,et al.Regulated expression of matrix metallo-proteinases and TIMP in nephrogenesis[J].Dev Dyn, 1998,213(2): 121.
  • 3Ebihar A,Nakamura T, Shimada N,et al.Increased plasma metalloproteimase-9 concentrations precede development of microalbuminaria in non-Insulin dependent diabetes mellitus[J].Am J Kidney Dis,1998,32(4):544.
  • 4Ota K,Stetler-stevenson WG,Yang Q,et al.Cloning of marine membrane-type-1-matrix metalloproteinase(MT-1-MMP) and its metanephric development regulation with respect to MMP-2 and its inhibitor[J].Kidmey Int, 1998,54(2): 131.
  • 5史应进,董玉红,王彩丽.血浆明胶酶检测在慢性肾脏疾病中的临床意义[J].放射免疫学杂志,2007,20(6):570-572. 被引量:7
  • 6Guarignata L, Whiting DR, Hambleton I, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035 [ J ]. Diabetes Res ClinPract, 2014, 103(2) : 137-149.
  • 7Reutens AT, Atkins RC. Epidemiology of diabetic nephropathy [J]. Diabetes and the Kidney, 2011, 170: 1-7.
  • 8Tonelli M, Muntner P, Lloyd A, et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study[ J]. Lancet, 2012, 380 (9844) : 807-814.
  • 9MacIsaac R J, Ekinci EI, Jerums G. Progressive diabetic nephropathy. How useful is microalbuminuria? contra[J]. Kidney Int, 2014, 86( 1 ) : 50-57.
  • 10Macisaac RJ, Jerums G. Diabetic kidney disease with and without albuminuria[ J ]. CurrOpinNephrolHypertens, 2011, 20 ( 3 ) : 246-257.

共引文献14

同被引文献38

引证文献4

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部